Emerging Growth News
Gemphire CEO Sooch: IPO funds will fuel research, staffing
|
On Aug. 5, after a six-week delay caused by market uncertainty over the United Kingdom's vote to exit the European Union, Gemphire Therapeutics ... ...read more
Growth Capitalist (https://growthcapitalist.com/author/bgoets/page/36/)
On Aug. 5, after a six-week delay caused by market uncertainty over the United Kingdom's vote to exit the European Union, Gemphire Therapeutics ... ...read more
Apollo Endosurgery, Lpath Apollo Endosurgery and Lpath Inc. (NSDQ:LPTN) said yesterday that they inked a reverse merger agreement that will see ... ...read more
If the private company becomes a publicly traded entity through a reverse merger, the element of the capital raise is still a completely separate ... ...read more
Apollo Endosurgery has struck a deal to acquire monoclonal antibody-focused Lpath in a reverse merger that will see the Apollo's investors adding ... ...read more